Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria
This study has been completed.
Study NCT00140361   Information provided by Centers for Disease Control and Prevention

First Received on August 30, 2005.   Last Updated on September 10, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria (Uncomplicated)
Additional conditions recognized in this trial
Malaria
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Sulfadoxine-pyrimethamine
lumefantrine plus artemether
Additional drug interventions recognized in this trial
Artemether
Artesunate
Lumefantrine
Pyrimethamine
Sulfadoxine
More general drug interventions related to this trial
Amebicides
Anthelmintics
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antifungal Agents
Antimalarials
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Coccidiostats
Enzyme Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Renal Agents
Schistosomicides
Therapeutic Uses
Sponsors listed in this trial
Centers for Disease Control and Prevention
United States Agency for International Development (USAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services